Analysis of Factors Affecting Venoarterial ECMO Oxygenator Performance Time Applied in Postcardiotomic Shock
PDF

Research Article

Analysis of Factors Affecting Venoarterial ECMO Oxygenator Performance Time Applied in Postcardiotomic Shock

Turk J Clin Cardiov Perfusion 2024;2(3):86-91 DOI: 10.4274/tjccp.galenos.2025.25338
PDF
Permissions

Abstract

Objective

The aim of the study is to analyze the factors affecting the efficiency of extracorporeal memb-rane oxygenation (ECMO), which is the average usage time. According to the results obtained, the aim is to determine the conditions under which oxygenator efficiency decreases, to maintain efficiency, and to reveal risk factors by preventing these problems in the early period.

Materials and Methods

Twent-one patients who underwent open heart surgery and ECMO at University of Health Sciences, Dr. Siyami Ersek Thoracic Cardiovascular Surgery Training and Research Hospital were included in the study. Age, gender, body surface area, presence of hypertension or diabetes mellitus, name of the operation, cardiopulmonary bypass time, cross-clamp time, cannula diameter, cannulation location and preoperative values (high-density lipoprotein, low-density lipoprotein and platelet) of these patients were recorded. During the postoperative period, ECMO, entry blood gases, and exit blood gases were taken daily from the oxygenator. Partial oxygen (PO2) values in this blood gas were recorded. ECMO revolutions per minute, liter volume per mi-nute, and pressure measurements at the oxygenator inlet and outlet were monitored. Activated clotting time follow-up was performed. Temperature measurements were made in the oxygenator. ECMO circuits were monitored for macroscopic thrombus formation. Along with the collected parameters, hemorrhagic values in the patients were statistically analyzed in 3 different time periods: T1 (2nd day), T2 (5th day) and Tlast (last day on ECMO).

Results

According to the results, since the p value between the last day and the 5th day of oxygenator output PO2 was p=0.001, a statistically significant result was obtained. No visible thrombus was found at T1 in n=21 patients examined as T1 (2nd day), T2 (5th day) and Tlast (last day). Thrombus developed in n=1 patient at T2 and in n=5 patients at Tlast. A significant difference was found in terms of thrombus development between T1 and Tlast values (p=0.019).

Conclusion

Based on the obtained data,studies with more cases may be guiding for the effects of signi-ficant changes in the measurements of the 2nd, 5th and last day of ECMO oxygenator efficiency or their role as a marker of efficiency.

Keywords: ECMO, postcardiotomic shock, oxygenator, thrombus, efficiency, anticoagulation

References

1

Sauer CM, Yuh DD, Bonde P. Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J (Am Soc Artif Intern Organs). 2015;61(1):31-36.

2

Sniecinski RM, Levy JH. Anticoagulation management associated with extracorporeal circulation. Best Pract Res Clin Anaesthesiol. 2015;29(2):189-202.

3

Esper SA, Levy JH, Waters JH, Welsby IJ. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesth Analg. 2014;118(4):731-743.

4

Lee YY, Baik HJ, Lee H, Kim CH, Chung RK, Han JI, et al. Heparin-free veno-venous extracorporeal membrane oxygenation in a multiple trauma patient: a case report. Medicine. 2020;99(5):e19070.

5

Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med. 2018;5:352.

6

Govindarajan V, Rakesh V, Reifman J, Mitrophanov AY. Computational study of thrombus formation and clotting factor effects under venous flow conditions. Biophys J. 2016;110(8):1869-1885.

7

Berg N, Fuchs G, Prahl Wittberg L. Flow and blood clot detection in the ECMO system. XXIV ICTAM. 21-26.08.2016; Montreal, Canada.

8

Chan SY, Figueroa M, Spentzas T, Powell A, Holloway R, Shah S. Prospective assessment of novice learners in a simulation-based extracorporeal membrane oxygenation (ECMO) education program. Pediatr Cardiol. 2013;34(3):543-552.

9

Whitman GJ. Extracorporeal membrane oxygenation for the treatment of postcardiotomy shock. J Thorac Cardiovasc Surg. 2017;153(1):95-101.

10

Pieri M, Belletti A, Monaco F, Pisano A, Musu M, Dalessandro V, et al. Outcome of cardiac surgery in patients with low preoperative ejection fraction. BMC Anesthesiol. 2016;16(1):97.

11

Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost. 2018;44(1):20-29.

12

Mazzeffi MA, Tanaka K, Roberts A, Rector R, Menaker J, Kon Z, et al. Bleeding, thrombosis, and transfusion with two heparin anticoagulation protocols in venoarterial ECMO patients. J Cardiothorac Vasc Anesth. 2019;33(5):1216-1220.